The Vanguard Group, Inc., commonly referred to as Vanguard, is a prominent American registered investment advisor founded in 1975.
Headquartered in Malvern, Pennsylvania, Vanguard has $9.3 trillion in assets under management (AUM) as of March 2024, ranking just behind BlackRock, which has $10.5 trillion in AUM.
Vanguard is the largest issuer of mutual funds globally and the second-largest issuer of exchange-traded funds (ETFs).
Here are six stocks that witnessed price fluctuations after Vanguard Group bought stake through a bulk deal on the NSE valued at over Rs. 600 crores on September 20th:
Arvind Fashions Limited
With a market cap of Rs. 8,077 crores, the shares of one of India’s top casual and denim players surged around 4.5 percent on BSE to Rs. 612.1 on Monday.
The Vanguard Group bought nearly 6.71 lakh equity shares in Arvind Fashions, at an average price of Rs. 588.68 per share, resulting in a total transaction value of nearly Rs. 39.55 crores.
The company has reported a significant growth in revenue from operations, with around a 10.2 percent YoY rise from Rs. 867 crores in Q1 FY24 to Rs. 955 crores in Q1 FY25. Similarly, the net profit grew from a loss of Rs. 5 crores to a profit of Rs. 14 crores, during the same period.
The stock has delivered positive returns of nearly 90 percent in one year, as well as around 47.4 percent returns year-to-date.
Arvind Fashions Limited is engaged in the business of designing, sourcing, marketing and selling branded readymade apparel, footwear, innerwear and other accessories for men, women and kids.
Five-Star Business Finance Limited
With a market cap of Rs. 23,167 crores, the shares of this Non-Banking Finance Company surged around 1.5 percent on BSE to Rs. 818.3 on Monday.
The Vanguard Group bought a total of nearly 37.78 lakh equity shares via different funds in Five-Star Business Finance, at an average price of Rs. 806.46 per share, resulting in a total transaction value of nearly Rs. 304.74 crores.
The company has reported a significant growth in revenue from operations, with around a 38.8 percent YoY rise from Rs. 480 crores in Q1 FY24 to Rs. 666 crores in Q1 FY25. Similarly, the net profit grew by 37 percent YoY from Rs. 184 crores to Rs. 252 crores, during the same period.
The stock has delivered positive returns of nearly 14 percent in one year, as well as around 7.8 percent returns year-to-date.
Five-Star Business Finance Limited, a systemically important non-deposit-taking NBFC, is primarily engaged in providing loans for business purposes, house renovation/extension purposes and other mortgage purposes.
Genus Power Infrastructures Limited
With a market cap of Rs. 12,821.5 crores, the shares of one of the largest players in India’s electricity metering solutions industry surged around 3.5 percent on BSE to Rs. 428.25 on Monday.
The Vanguard Group bought nearly 15.19 lakh equity shares in Genus Power Infra, at an average price of Rs. 416.31 per share, resulting in a total transaction value of nearly Rs. 63.26 crores.
The company has reported a significant growth in revenue from operations, with around a 58.6 percent YoY rise from Rs. 261 crores in Q1 FY24 to Rs. 414 crores in Q1 FY25. Similarly, the net profit grew by 108.7 percent YoY from Rs. 23 crores to Rs. 48 crores, during the same period.
The stock has delivered positive returns of nearly 2.2 percent in one year, as well as around 2 percent returns year-to-date.
Genus Power Infrastructures Limited is engaged in the business of manufacturing and providing metering and metering solutions and undertaking engineering, construction and contracts on a turnkey basis.
Sansera Engineering Limited
With a market cap of Rs. 9,159.7 crores, the shares of a company engaged in manufacturing precision-engineered components for the automotive and non-automotive sectors surged around 2.3 percent on BSE to Rs. 1,699.9 on Monday.
The Vanguard Group bought nearly 3.19 lakh equity shares in Sansera Engineering, at an average price of Rs. 1,669.38 per share, resulting in a total transaction value of nearly Rs. 53.28 crores.
The company has reported a significant growth in revenue from operations, with around a 12.7 percent YoY rise from Rs. 660 crores in Q1 FY24 to Rs. 744 crores in Q1 FY25. Similarly, the net profit grew by 11 percent YoY from Rs. 45 crores to Rs. 50 crores, during the same period.
The stock has delivered positive returns of nearly 80.4 percent in one year, as well as around 61.8 percent returns year-to-date.
Incorporated in 1981, Sansera Engineering Limited is involved in the business of manufacturing auto components such as rocker arms, connecting rods, gear shifters, crankshafts, and aerospace components, along with providing services such as forging and other related services.
VA Tech Wabag Limited
With a market cap of Rs. 9,266.4 crores, the shares of one of the world’s leading companies in the water treatment sector slumped marginally by around 0.3 percent on BSE to Rs. 1,516.75 on Monday.
The Vanguard Group bought nearly 3.13 lakh equity shares in VA Tech Wabag, at an average price of Rs. 1,516.23 per share, resulting in a total transaction value of nearly Rs. 47.48 crores.
The company has reported a significant growth in revenue from operations, with around a 13.2 percent YoY rise from Rs. 553 crores in Q1 FY24 to Rs. 626 crores in Q1 FY25. Similarly, the net profit grew by 10 percent YoY from Rs. 50 crores to Rs. 55 crores, during the same period.
The stock has delivered multibagger returns of nearly 217.4 percent in one year, as well as around 133.5 percent returns year-to-date.
VA Tech Wabag Limited is primarily engaged in the design, supply, installation, construction, O&M of drinking water, wastewater treatment, industrial water treatment and desalination plants including production of energy from biogas and sludge management.
Marksans Pharma Limited
With a market cap of Rs. 14,292.8 crores, the shares of a pharmaceutical company surged around 3 percent on BSE to Rs. 327.7 on Monday.
The Vanguard Group bought a total of nearly 50 lakh equity shares in Marksans Pharma via different funds, at an average price of Rs. 316.85 per share, resulting in a total transaction value of nearly Rs. 158.4 crores.
The company has reported a significant growth in revenue from operations, with around a 18.2 percent YoY rise from Rs. 500 crores in Q1 FY24 to Rs. 591 crores in Q1 FY25. Similarly, the net profit grew by 27.2 percent YoY from Rs. 70 crores to Rs. 89 crores, during the same period.
The stock has delivered multibagger returns of nearly 198.2 percent in one year, and around 96.5 percent of positive returns year-to-date.
Marksans Pharma Limited is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
